{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:39:51Z","timestamp":1790732391717,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bioorg.2019.103364","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T01:51:58Z","timestamp":1571363518000},"page":"103364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA)"],"prefix":"10.1016","volume":"94","author":[{"given":"Mohamed H.","family":"Hannoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hagras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Aziz M.M.","family":"El-Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamada S.","family":"Abulkhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103364_b0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/589241","article-title":"Risk of infection and death due to methicillin-resistant staphylococcus aureus in long-term carriers","volume":"47","author":"Datta","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2019.103364_b0010","doi-asserted-by":"crossref","unstructured":"T.F. Landers, B. Cohen, T.E. Wittum, E.L. Larson, A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential, Public Health Rep. 127 (2012) 4\u201322.","DOI":"10.1177\/003335491212700103"},{"key":"10.1016\/j.bioorg.2019.103364_b0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jac\/dkt301","article-title":"Antibiotic prescribing for adults in ambulatory care in the USA, 2007\u201309","volume":"69","author":"Shapiro","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2019.103364_b0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2019.103364_b0025","doi-asserted-by":"crossref","unstructured":"A. Husain, V. Rawat, Umesh, M. Kumar, P.K. Verma, Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center., J. Lab. Physicians. 10 (n.d.) 145\u2013148.","DOI":"10.4103\/JLP.JLP_92_17"},{"key":"10.1016\/j.bioorg.2019.103364_b0030","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/jm401905m","article-title":"Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus","volume":"57","author":"Mohammad","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejmech.2015.03.015","article-title":"Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"94","author":"Mohammad","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrmicro2677","article-title":"From the regulation of peptidoglycan synthesis to bacterial growth and morphology","volume":"10","author":"Typas","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2019.103364_b0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pro.2414","article-title":"Resistance to antibiotics targeted to the bacterial cell wall","volume":"23","author":"Nikolaidis","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2019.103364_b0050","first-page":"1","article-title":"Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant","author":"Mohammad","year":"2014","journal-title":"Staphylococci., J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bioorg.2019.103364_b0055","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejmech.2017.08.039","article-title":"Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis","volume":"139","author":"Eid","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0060","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1016\/j.bmc.2012.10.006","article-title":"Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1)","volume":"20","author":"Mayhoub","year":"2012","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0065","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1021\/acs.jmedchem.6b00233","article-title":"Second-generation phenylthiazole antibiotics with enhanced pharmacokinetic properties","volume":"59","author":"Seleem","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0070","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1021\/acs.jmedchem.6b01780","article-title":"Phenylthiazole antibacterial agents targeting cell wall synthesis exhibit potent activity in vitro and in vivo against vancomycin-resistant enterococci","volume":"60","author":"Mohammad","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0075","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.8b00172","article-title":"Naphthylthiazoles: targeting multidrug-resistant and intracellular staphylococcus aureus with biofilm disruption activity","author":"Hagras","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2019.103364_b0080","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ejmech.2017.10.048","article-title":"Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability","volume":"143","author":"Hagras","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0085","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1039\/C8RA10525A","article-title":"tert -Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity","volume":"9","author":"Kotb","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.103364_b0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4155\/fmc-2017-0159","article-title":"Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus","volume":"10","author":"Zheng","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0095","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/jm501661f","article-title":"Structure-activity relationship for the oxadiazole class of antibiotics","volume":"58","author":"Spink","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bioorg.2017.12.001","article-title":"Oxindole based oxadiazole hybrid analogs : Novel a -glucosidase inhibitors","volume":"76","author":"Taha","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.07.009","article-title":"Synthesis, a -glucosidase inhibitory activity and in silico study of tris -indole hybrid scaffold with oxadiazole ring : As potential leads for the management of type-II diabetes mellitus","volume":"74","author":"Taha","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0110","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1016\/j.bmc.2015.06.060","article-title":"Bioorganic & medicinal chemistry synthesis of new oxadiazole derivatives as a -glucosidase inhibitors","volume":"23","author":"Taha","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0115","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1016\/j.bmc.2015.10.037","article-title":"Bioorganic & medicinal chemistry synthesis of novel benzohydrazone \u2013 oxadiazole hybrids as b -glucuronidase inhibitors and molecular modeling studies","volume":"23","author":"Taha","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0120","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1016\/j.bmc.2010.09.051","article-title":"Bioorganic & Medicinal Chemistry Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1, 3, 4-oxadiazole moiety as potential antitumor agents","volume":"18","author":"Zheng","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0125","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/jm1013538","article-title":"Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins","volume":"54","author":"Mayhoub","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0130","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1021\/acs.jmedchem.7b00392","article-title":"Investigating the antibacterial activity of biphenylthiazoles against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)","volume":"60","author":"Hagras","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b9000","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bioorg.2017.04.014","article-title":"Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitors","volume":"72","author":"Ihmaid","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b9005","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/jhet.714","article-title":"Synthesis and evaluation of some new (1,2,4) triazolo(4,3-a)quinoxalin-4(5H)-one derivatives as AMPA receptor antagonists","volume":"50","author":"Abul-Khair","year":"2013","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b9010","first-page":"338","article-title":"Synthesis and preliminary antimicrobial evaluation of some new 6-methoxyquinoline-3-carbonitrile derivatives","volume":"4","author":"Hagrs","year":"2015","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"10.1016\/j.bioorg.2019.103364_b9015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4172\/2161-0444.1000404","article-title":"Molecular docking, synthesis and biological evaluation of some novel 2-substituted-3-allyl-4(3H)-quinazolinone derivatives as anticonvulsant agents","volume":"6","author":"Abulkhair","year":"2016","journal-title":"Med. Chem. (Los. Angeles)"},{"key":"10.1016\/j.bioorg.2019.103364_b9020","first-page":"1","article-title":"Synthesis, characterization and in vitro antitumor evaluation of new pyrazolo[3,4-d]pyrimidine derivatives","volume":"07","author":"El-Morsy","year":"2017","journal-title":"Open J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103364_b0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819306698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819306698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:02:19Z","timestamp":1758614539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819306698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":32,"alternative-id":["S0045206819306698"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103364","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103364"}}